Compare AMBALAL SARABHAI with ISHITA DRUGS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI vs ISHITA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMBALAL SARABHAI ISHITA DRUGS AMBALAL SARABHAI/
ISHITA DRUGS
 
P/E (TTM) x 4.6 13.3 34.8% View Chart
P/BV x 2.9 1.7 177.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMBALAL SARABHAI   ISHITA DRUGS
EQUITY SHARE DATA
    AMBALAL SARABHAI
Mar-21
ISHITA DRUGS
Mar-20
AMBALAL SARABHAI/
ISHITA DRUGS
5-Yr Chart
Click to enlarge
High Rs3122 142.0%   
Low Rs1510 142.6%   
Sales per share (Unadj.) Rs21.449.6 43.0%  
Earnings per share (Unadj.) Rs2.61.8 144.4%  
Cash flow per share (Unadj.) Rs3.02.4 121.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs9.623.3 41.4%  
Shares outstanding (eoy) m76.632.99 2,562.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.10.3 330.2%   
Avg P/E ratio x8.78.8 98.5%  
P/CF ratio (eoy) x7.86.7 116.5%  
Price / Book Value ratio x2.40.7 343.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,75748 3,643.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2828 3,697.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,636148 1,103.3%  
Other income Rs m3062 18,875.9%   
Total revenues Rs m1,942150 1,295.3%   
Gross profit Rs m-158 -202.0%  
Depreciation Rs m242 1,362.7%   
Interest Rs m320 9,137.1%   
Profit before tax Rs m2347 3,286.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m322 1,919.9%   
Profit after tax Rs m2025 3,700.5%  
Gross profit margin %-0.95.1 -18.3%  
Effective tax rate %13.623.3 58.3%   
Net profit margin %12.43.7 335.3%  
BALANCE SHEET DATA
Current assets Rs m1,20680 1,506.1%   
Current liabilities Rs m1,28524 5,467.5%   
Net working cap to sales %-4.938.1 -12.7%  
Current ratio x0.93.4 27.5%  
Inventory Days Days66132 50.1%  
Debtors Days Days86632 2,683.5%  
Net fixed assets Rs m87214 6,254.4%   
Share capital Rs m76630 2,563.0%   
"Free" reserves Rs m-2740 -68.9%   
Net worth Rs m73970 1,061.6%   
Long term debt Rs m520 12,319.0%   
Total assets Rs m2,07894 2,210.2%  
Interest coverage x8.321.4 39.0%   
Debt to equity ratio x0.10 1,160.4%  
Sales to assets ratio x0.81.6 49.9%   
Return on assets %11.36.2 182.3%  
Return on equity %27.47.9 348.5%  
Return on capital %33.710.7 315.2%  
Exports to sales %00-   
Imports to sales %018.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA27 0.0%   
Fx inflow Rs m07 0.0%   
Fx outflow Rs m027 0.0%   
Net fx Rs m0-21 0.0%   
CASH FLOW
From Operations Rs m-2310 -219.4%  
From Investments Rs m101-12 -875.1%  
From Financial Activity Rs m-581 -6,212.8%  
Net Cashflow Rs m200 -16,258.3%  

Share Holding

Indian Promoters % 30.8 47.9 64.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 69.2 52.1 132.8%  
Shareholders   185,749 4,787 3,880.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMBALAL SARABHAI With:   SUN PHARMA  SYNCOM FORMULATIONS  LINCOLN PHAR  VIVIMED LABS  RPG LIFE SCIENCES  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMBALAL SARABHAI SHARE PRICE


Dec 3, 2021 (Close)

TRACK AMBALAL SARABHAI

  • Track your investment in AMBALAL SARABHAI with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AMBALAL SARABHAI

AMBALAL SARABHAI 5-YR ANALYSIS

COMPARE AMBALAL SARABHAI WITH

MARKET STATS